Health, Longevity & Biohacking
Two-Thirds of GLP-1 Users Stop Within One Year Due to Side Effects
ZOE Science & Nutrition
The 4 rules to protect your muscle, bones and brain health when using Ozempic and other weight loss injections | Dr Federica Amati
What was said
"Depending on which study you look at, it's about 50 to 60% of people stop taking the drug within a year. In some analyses, it's two-thirds of people stop because they can't tolerate the side effects or because they can't afford to keep paying out of pocket for it."
Real-world data shows a massive dropout rate among Ozempic and Mounjaro users, with most stopping due to gastrointestinal side effects that could be managed through proper dietary intervention. The revelation highlights a critical gap between the drugs' promise and their practical application, particularly for those accessing them outside traditional medical supervision.
Verification status
Attributed speaker claim
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
Source and context
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
- Programme
- ZOE Science & Nutrition
- Episode
- The 4 rules to protect your muscle, bones and brain health when using Ozempic and other weight loss injections | Dr Federica Amati
- Clip time
- 8:35
- Original source
- Watch the source segment →
From this episode
ZOE Science & Nutrition